Eli Lilly & Co. Bulks Up Irish Operations in Obesity Drug Production Push
David Ricks, chief executive officer of Eli Lilly & Co., outside the company's manufacturing plant in Limerick, Ireland, on Thursday, Sept. 12, 2024. Lilly has been bulking up its production capacity since 2020, investing more than $17 billion into developing new plants and expanding existing facilities for the weight-loss and diabetes drugs that are expected to become some of the best-selling medicines of all time. Photographer: Paulo Nunes dos Santos/Bloomberg via Getty Images

PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesEli Lilly & Co. Bulks Up Irish Operations in Obesity Drug..., News Photo
Eli Lilly & Co. Bulks Up Irish Operations in Obesity Drug... Get premium, high resolution news photos at Getty ImagesProduct #:2170747210
Eli Lilly & Co. Bulks Up Irish Operations in Obesity Drug... Get premium, high resolution news photos at Getty ImagesProduct #:2170747210$499$175
Getty Images
In stockDETAILS
Credit: Bloomberg / Contributor
Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Editorial #:
2170747210
Collection:
Bloomberg
Date created:
September 12, 2024
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
IRELAND ELI LILLY
Max file size:
5452 x 3635 px (18.17 x 12.12 in) - 300 dpi - 5 MB